The Food and Drug Administration granted marketing approval to Lannett Co. Inc. for its generic version of Phentermine hydrochloride, a weight-reduction medicine marketed by Sandoz. (Source: bizjournals.com Health Care:Health Insurance headlines)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
The Food and Drug Administration granted marketing approval to Lannett Co. Inc. for its generic version of Phentermine hydrochloride, a weight-reduction medicine marketed by Sandoz. (Source: bizjournals.com Health Care:Biotechnology headlines)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
Major Finding: In patients on the highest dose of phentermine plus controlled-release topiramate, systolic BP reductions were significantly lower than with placebo: 3.4 mm Hg after 28 weeks in EQUATE, 3.8 mm Hg after 56 weeks in EQUIP, and 3.2 mm Hg after 56 weeks in CONQUER. (Source: Clinical Endocrinology News)
SAN DIEGO (MedPage Today) — A combination of phentermine and topiramate (Qnexa) appears to induce weight loss and a decrease in metabolic risk parameters for cardiovascular disease in obese patients, researchers reported here. (Source: MedPage Today Endocrinology)
MedWorm Message: Register for MedMatcha, MedWorm’s m edical advertising network, and receive $5 free advertising.
Major Finding: In patients on the highest dose of phentermine plus controlled-release topiramate, systolic blood pressure reductions were significantly lower than with placebo: 3.4 mm Hg after 28 weeks in EQUATE, 3.8 mm Hg after 56 weeks in EQUIP, and 3.2 mm Hg after 56 weeks in CONQUER. (Source: Family Practice News)
Major Finding: In patients on the highest dose of phentermine plus controlled-release topiramate, systolic blood pressure reductions were significantly lower than with placebo: 3.4 mm Hg after 28 weeks in EQUATE, 3.8 mm Hg after 56 weeks in EQUIP, and 3.2 mm Hg after 56 weeks in CONQUER. (Source: Cardiology News)
The highest dose of an investigational weight-loss therapy, a combination of very low-dose phentermine and controlled-release topiramate, reduces body weight by around 10% after a year of treatment…
For complete story visit theheart.org. (Source: theHeart.org)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free adver tising.
BIRMINGHAM, Ala. â Research by a University of Alabama at
Birmingham (UAB) professor shows an association between hearing
loss and the use of the erectile dysfunction drug Viagra.
Findings published May 18 in Archives of Otolaryngology-Head… (Source: Drugs.com – Clinical Trials)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and recei ve $5 free advertising.
BIRMINGHAM, Ala., May 19 (UPI) — U.S. researchers found an association between hearing loss and use of Viagra, the erectile dysfunction medication. (Source: Health News – UPI.com)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.
The erectile dysfunction drug Viagra, and possibly other similar medications, may prompt long-term hearing loss among users, a new study sug … (Source: USATODAY.com Health)
MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.